Clinical Trial Update: Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus. [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy and safety of pioglitazone for vascular complications in type 2 diabetes mellitus; the study sponsored by Takeda is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Actos (Pioglitazone)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED